No Data
No Data
Express News | Guggenheim Reiterates Buy on ProMIS Neurosciencesto Buy
ProMIS Neurosciences Analyst Ratings
ProMIS Neurosciences Doses First Patiets in Phase 1b PRECISE-AD Trial
Express News | ProMIS Neurosciences Inc - Six-Month Interim Results Expected in 1H 2026, Topline Results in 2H 2026
ProMIS Neurosciences Separates With Operating Chief, Won't Backfill Role
ProMIS Neurosciences Executive Makes Bold Stock Purchase
Lnova : thanks for posting
![undefined [undefined]](https://static.moomoo.com/nnq/emoji/static/image/default/default-black.png?imageMogr2/thumbnail/36x36)